Pitt Shield

A PVDF Receiver for Acoustic Monitoring of Microbubble-Mediated Ultrasound Brain Therapy.

Authors: Lin Y, O'Reilly MA, Hynynen K

The real-time monitoring of spectral characteristics of microbubble (MB) acoustic emissions permits the prediction of increases in blood-brain barrier (BBB) permeability and of tissue damage in MB-mediated focused ultrasound (FUS) brain therapy. Single-element passive cavitation detectors provide limited spatial information regarding MB activity, greatly affecting the performance of acoustic control. However, an array of receivers can be used to spatially map cavitation events and thus improve treatment control. The spectral content of the acoustic emissions provides additional information that can be correlated with the bio-effects, and wideband receivers can thus provide the most complete spectral information. Here, we develop a miniature polyvinylidene fluoride (PVDF thickness = 110 μm, active area = 1.2 mm<sup>2</sup>) broadband receiver for the acoustic monitoring of MBs. The receiver has superior sensitivity (2.36-3.87 V/MPa) to those of a commercial fibre-optic hydrophone in the low megahertz frequency range (0.51-5.4 MHz). The receiver also has a wide -6 dB acceptance angle (54 degrees at 1.1 MHz and 13 degrees at 5.4 MHz) and the ability to detect subharmonic and higher harmonic MB emissions in phantoms. The overall acoustic performance of this low-cost receiver indicates its suitability for the eventual use within an array for MB monitoring and mapping in preclinical studies.

Introduction

Purpose Drug delivery with BBB opening
Study Objective Develop and characterize a miniature broadband PVDF receiver for sensitive acoustic monitoring and spatial mapping of microbubble cavitation during focused ultrasound brain therapy.

Outcomes and Safety

Summary of Outcomes A miniature PVDF broadband receiver (110 μm thick, 1.2 mm²) exhibited superior sensitivity (2.36–3.87 V/MPa) to a commercial fibre‑optic hydrophone, wide −6 dB acceptance angles (54° at 1.1 MHz, 13° at 5.4 MHz), and reliably detected subharmonic and higher harmonic microbubble emissions across 0.51–5.4 MHz in phantoms, indicating suitability for arrayed monitoring to predict BBB permeability and tissue damage in FUS therapy.
Safety-related matter The paper notes that microbubble-mediated focused ultrasound can cause increases in blood–brain barrier permeability and tissue damage, and that real-time spectral monitoring of acoustic emissions can predict these adverse effects.

Brain Region

Visualization unavailable

Ultrasound Parameters

Ultrasound instrument Miniature polyvinylidene fluoride (PVDF) broadband receiver; PVDF thickness = 110 μm; active area = 1.2 mm^2; Manufacturer: None
FUS Frequency 0.51–5.4 MHz (including specific mentions of 1.1 MHz and 5.4 MHz)
Focal Characteristics Focal depth: None; Focal length: None; Aperture size: 1.2 mm^2

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search